Mjaaland M, Unneberg K, Hotvedt R, Revhaug A
Department of Surgery, Tromsø University Hospital, Norway.
Eur J Surg. 1991 Jan;157(1):21-7.
Nineteen patients undergoing elective gastrointestinal surgery were randomised to receive recombination human growth hormone (n = 9) or placebo (n = 10) for the first five postoperative days. All received epidural analgesia and total parenteral nutrition during the same period (energy supply 125% of basal metabolic rate, mean nitrogen (+/- SEM) 5.7 (+/- 0.1) g/m2). Nitrogen and potassium retention was induced in the growth hormone group compared with the placebo group (cumulative nitrogen balance 4.1 (+/- 1.1) g/m2 in the growth hormone group and -3.1 (+/- 1.8) g/m2 in the placebo group, p less than 0.01; cumulative potassium balance 80.8 (+/- 4.7) mmol/m2 in the growth hormone group and 43.1 (+/- 11.4) mmol/m2 in the placebo group, p less than 0.01). In the growth hormone group, serum glucose concentrations increased each evening and mean serum albumin concentrations were reduced throughout the period; the morning pulse rates were decreased, and the patients gained weight compared with the placebo group.
19例接受择期胃肠手术的患者被随机分为两组,术后前5天分别接受重组人生长激素(n = 9)或安慰剂(n = 10)治疗。在此期间,所有患者均接受硬膜外镇痛和全胃肠外营养(能量供应为基础代谢率的125%,平均氮摄入量(±标准误)为5.7(±0.1)g/m²)。与安慰剂组相比,生长激素组出现氮和钾潴留(生长激素组累积氮平衡为4.1(±1.1)g/m²,安慰剂组为-3.1(±1.8)g/m²,p<0.01;生长激素组累积钾平衡为80.8(±4.7)mmol/m²,安慰剂组为43.1(±11.4)mmol/m²,p<0.01)。在生长激素组中,血清葡萄糖浓度每晚升高,整个期间平均血清白蛋白浓度降低;与安慰剂组相比,早晨脉搏率降低,患者体重增加。